Your session is about to expire
← Back to Search
Antiretroviral Agent
Study Participants for Liver Disease (VAMOS Trial)
N/A
Waitlist Available
Led By Jordan Lake, MD
Research Sponsored by Theratechnologies
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
No Placebo-Only Group
Summary
The Visceral Adiposity Measurement and Observation Study
Eligible Conditions
- Fatty Liver
- Liver scarring
- Liver Disease
- Nonalcoholic fatty liver disease
- Fatty Liver Disease
- HIV Lipodystrophy Syndrome
- HIV/AIDS
- HIV
- HIV Infection
- Lipohypertrophy
- Non-alcoholic Fatty Liver Disease
- Liver Fibrosis
- Waist Measurement
- Body Mass Index
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Iliac waist circumference measurement (in cm).
Umbilical waist circumference measurement (in cm).
Visceral Adiposity Measurement by CT surface area (cm2).
Secondary study objectives
Fibroscan Controlled Attenuation Parameter (CAP) in decibels/minute
Fibroscan Vibration Controlled Transient Elastography (VCTE) in kPa
Framingham Cardiovascular Risk strata (low, intermediate or high)
+6 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Study ParticipantsExperimental Treatment2 Interventions
Waist and hip circumferences, CT Scan and FibroScan and Quality of Life questionnaire, vital signs, urine and blood testing in Adults with HIV on continuous Anti-Retroviral Therapy treatment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Diagnostic Test
2022
N/A
~2120
HIV Anti-retroviral Background Therapy
2022
N/A
~200
Find a Location
Who is running the clinical trial?
Norwich Clinical Research Associates Ltd.OTHER
4 Previous Clinical Trials
596 Total Patients Enrolled
TheratechnologiesLead Sponsor
10 Previous Clinical Trials
2,082 Total Patients Enrolled
Medpace, Inc.Industry Sponsor
96 Previous Clinical Trials
29,681 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger